0001650840-19-000002.txt : 20190610 0001650840-19-000002.hdr.sgml : 20190610 20190607191651 ACCESSION NUMBER: 0001650840-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190610 DATE AS OF CHANGE: 20190607 EFFECTIVENESS DATE: 20190610 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dance Biopharm Holdings, Inc. CENTRAL INDEX KEY: 0001650840 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-341491 FILM NUMBER: 19887265 BUSINESS ADDRESS: STREET 1: 2 MINT PLAZA, SUITE 804 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 415-369-9415 MAIL ADDRESS: STREET 1: 2 MINT PLAZA, SUITE 804 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: Dance BioPharm Holdings, Inc. DATE OF NAME CHANGE: 20150812 D 1 primary_doc.xml X0708 D LIVE 0001650840 Dance Biopharm Holdings, Inc. 2 MINT PLAZA, SUITE 804 SAN FRANCISCO CA CALIFORNIA 94103 415-369-9415 DELAWARE SAV Holdings Corp. Dance BioPharm Holdings, Inc. Corporation true John S. Patton, Ph.D 2 Mint Plaza, Suite 804 San Francisco CA CALIFORNIA 94103 Executive Officer Director Anne Whitaker 2 Mint Plaza, Suite 804 San Francisco CA CALIFORNIA 94103 Executive Officer Director Ben Wolin 2 Mint Plaza, Suite 804 San Francisco CA CALIFORNIA 94103 Director Matt Jennings 2 Mint Plaza, Suite 804 San Francisco CA CALIFORNIA 94103 Director Steven Thornton 2 Mint Plaza, Suite 804 San Francisco CA CALIFORNIA 94103 Director Adam K. Stern c/o Aegis Capital Corp. 810 Seventh Ave., 18th Floor New York NY NEW YORK 10019 Director Mike Kaseta 2 Mint Plaza, Suite 804 San Francisco CA CALIFORNIA 94103 Executive Officer Dr. Melissa Rhodes 2 Mint Plaza, Suite 804 San Francisco CA CALIFORNIA 94103 Executive Officer Biotechnology Decline to Disclose 06b false 2019-01-07 false true true false 0 Aegis Capital Corp 15007 None None 810 Seventh Avenue, 18th Floor New York NY NEW YORK 10019 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA IA IOWA MD MARYLAND MA MASSACHUSETTS MN MINNESOTA MS MISSISSIPPI MO MISSOURI NE NEBRASKA NV NEVADA NJ NEW JERSEY NM NEW MEXICO NY NEW YORK NC NORTH CAROLINA OH OHIO OR OREGON PA PENNSYLVANIA SC SOUTH CAROLINA TN TENNESSEE TX TEXAS VT VERMONT VA VIRGINIA WA WASHINGTON WI WISCONSIN false 59200000 21046000 38154000 false 283 825280 true 0 Placement agent is entitled to receive up to 5% of the aggregate gross proceeds from the exercise of warrants, together with a non-accountable expense allowance equal to up to 3% of the aggregate gross proceeds. 0 true Proceeds to be used as working capital, including payment of officer and employee salaries. A portion of the proceeds to be used to compensate Placement Agent. Adam Stern, a director of the issuer, is an affiliate of the Placement Agent. false Dance Biopharm Holdings, Inc. /Anne Whitaker/ Anne Whitaker Chief Executive Officer 2019-06-07